Literature DB >> 2558678

Ability of periaqueductal gray subdivisions and adjacent loci to elicit analgesia and ability of naloxone to reverse analgesia.

B E Thorn1, L Applegate, S W Johnson.   

Abstract

This study is an investigation of the effects of stimulation of regions within and adjacent to the periaqueductal gray (PAG) matter. Eighty-five rats were implanted with 1 monopolar stimulating electrode into 1 of 5 loci. Potency of analgesia was evaluated by relative increases in tailflick latencies after brain stimulation, and threshold current intensity was used to elicit analgesia. The ability of naloxone to reverse the stimulation-induced analgesia was also evaluated. Results replicate the previous finding of differential naloxone reversibility of ventral vs. dorsal PAG sites, but they do not support a regional distinction in the potency of analgesia induced. The results suggest that dorsal PAG sites are involved in a separate nonopiate pain-inhibitory system, whereas ventral sites are involved in an opiate system. These systems, however, do not respect the cytoarchitectural boundaries of the PAG because sites adjacent to the PAG elicit similar effects with a corresponding dorsal-ventral distinction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558678     DOI: 10.1037//0735-7044.103.6.1335

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  3 in total

1.  Midbrain central gray GABAA receptor activation enhances, and blockade reduces, sexual behavior in the female rat.

Authors:  M M McCarthy; D W Pfaff; S Schwartz-Giblin
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  The relative efficacy of monopolar vs. bipolar electrodes in stimulation-produced analgesia.

Authors:  B E Thorn; L Applegate; K Jones
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

3.  μ-Opioid receptors in primary sensory neurons are involved in supraspinal opioid analgesia.

Authors:  Jie Sun; Shao-Rui Chen; Hui-Lin Pan
Journal:  Brain Res       Date:  2019-12-24       Impact factor: 3.252

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.